Type 2 phosphatidylinositol-5-phosphate 4-kinase (PI5P4K) converts phosphatidylinositol-5-phosphate to phosphatidylinositol-4,5-bisphosphate. Mammals have three enzymes PI5P4Kα, PI5P4Kβ, and PI5P4Kγ, and these enzymes have been implicated in metabolic control, growth control, and a variety of stress responses. Here, we show that mice with germline deletion of type 2 phosphatidylinositol-5-phosphate 4-kinase gamma (Pip4k2c), the gene encoding PI5P4Kγ, appear normal in regard to growth and viability but have increased inflammation and T-cell activation as they age. Immune cell infiltrates increased in Pip4k2c −/− mouse tissues. Also, there was an increase in proinflammatory cytokines, including IFNγ, interleukin 12, and interleukin 2 in plasma of Pip4k2c −/− mice. Pip4k2c −/− mice had an increase in T-helper-cell populations and a decrease in regulatory T-cell populations with increased proliferation of T cells. Interestingly, mammalian target of rapamycin complex 1 (mTORC1) signaling was hyperactivated in several tissues from Pip4k2c −/− mice and treating Pip4k2c
, indicating a synthetic lethality relationship between these genes. In contrast, Pip4k2a −/− mice do not exhibit any of the phenotypes observed in the Pip4k2b −/− mice (5). They are not protected from obesity or insulin resistance, they do not exhibit a synthetic lethality relationship with Trp53, and in all ways examined, they resemble wild-type mice (5) . However, germline deletion of one allele of Pip4k2a in the context of germline Pip4k2b −/− causes enhancement of the phenotypes of the Pip4k2b −/− mice. Deletion of both alleles of Pip4k2a and Pip4k2b did not have any observable effect on embryonic development up until the time of birth, but resulted in perinatal lethality of all pups. These results indicate that these genes do not play a major role in embryonic development and that Pip4k2a provides a backup for Pip4k2b that becomes critical at the time of birth.
Significance
The mammalian target of rapamycin complex 1 (mTORC1) signaling pathway is an important facet of the immune system, including that it regulates T-cell differentiation and activation. Here, we report that type 2 phosphatidylinositol-5-phosphate 4-kinase gamma (protein, PI5P4Kγ; gene, PIP4K2C) plays a role in the regulation of the immune system by manipulating mTORC1 signaling. These results suggest that the SNP at the PIP4K2C locus (rs1678542) in human patients with autoimmunity might cause a decrease in PI5P4Kγ expression and thereby an increase in mTORC1 signaling. In addition, these results imply that inhibition of mTORC1 would be beneficial to these patients. These studies also suggest that agents that inhibit PIP4K2C function could be useful to enhance cancer immunotherapy.
Whereas less is known about PI5P4Kγ, it has been linked to the mammalian target of rapamycin signaling complex (mTORC) and to cellular immunity. Mackey et al. argued that PI5P4Kγ was negatively regulated by mTORC1 through direct phosphorylation at serine 324 and serine 328 (6) . On the other hand, it was reported that knocking out the only PI5P4K isoform in Drosophila resulted in lower body weight and that this correlated with decreased mTORC1 signaling (7) . Of particular interest, multiple studies have shown a link between a SNP (rs1678542) in the human PIP4K2C locus and familial autoimmunity (8, 9) . The immune system is a complex network that evolved to protect organisms from invasion of various microbes. Whereas an active immune system protects from microbes, overactivation of the immune system can result in autoimmunity. An understanding of the molecular underpinnings of an overactive or underactive immune system is important for developing therapies for immunerelated diseases from immunodeficiency to autoimmunity and even cancers. mTORC1, a central regulator of cell survival, growth, and metabolism, also plays a critical role in regulation of immune cells. mTORC1 responds to intra-and extracellular signals such as growth factors, oxygen levels, energy status, and amino acid levels (10) . The mTOR pathway is activated during various cellular processes, including T-cell activation, insulin resistance, and tumor formation. The immunosuppressive drug rapamycin that has been used clinically to prevent transplant rejection, directly binds to mTORC1 to suppress immune responses (11) . One of the identified roles of mTORC1 in the immune system is to direct T-cell-fate decisions. mTORC1 positively regulates differentiation of the Th1 and Th17 subset of Th cells (12) . On the other hand, mTORC1 is a negative regulator of Treg differentiation (13) and at the same time is required to maintain Treg function (14) .
Here, we present the first characterization to our knowledge of mice with germline deletion of Pip4k2c. Surprisingly, Pip4k2c −/− mice exhibit a phenotype that is quite different from Pip4k2a −/− or Pip4k2b −/− mice. These mice develop normally and are not protected from obesity, insulin resistance, or diabetes, but rather develop enhanced immune responses, resulting in autoimmunity.
In addition, they exhibit hyperactivation of mTORC1 signaling in multiple tissues, suggesting that Pip4k2c negatively regulates mTORC1. These results, along with a recent observation that the enzyme encoded by this gene is a substrate of mTORC1 (6) , suggest a close relationship between mTORC1 and Pip4k2c. Moreover, the hyperimmune phenotype of the Pip4k2c −/− mice could be partially ameliorated by treatment with the mTORC1 inhibitor, rapamycin. Importantly, a SNP (rs1678542) located near the PIP4K2C locus has been correlated with familial autoimmunity (8) and the results presented here suggest that loss of PI5P4Kγ function could explain this disease.
Results

Generation of Pip4k2c
−/− Mice. To investigate the role of PI5P4Kγ in mammals, PI5P4Kγ knockout (Pip4k2c −/− ) mice were generated using Pip4k2c-targeted ES cell clones obtained from the knockout mouse project (KOMP) repository (www.komp.org). In the targeting construct, exons 3 and 4 of Pip4k2c were bracketed by loxP sequences, so deletion of these exons could remove much of the kinase domain and place the protein out of the correct reading frame (Fig. 1A) . ES cell clones were karyotyped and selected for microinjection. Because the targeted clones were C57BL/6N (agouti)-derived JM8A3.N1, the cells were injected into C57BL/6J (black) blastocysts. Three chimeric mice were born and they were backcrossed with C57BL/6 mice for three generations. Then whole body knockout mice were obtained by crossing the transgenic mice with B6.C-Tg(CMVcre)1Cgn/J. The Pip4k2c +/− mice were crossed with Pip4k2c
+/− mice to get Pip4k2c +/+ (WT) mice and Pip4k2c −/− (KO) mice to use for the ensuing experiments. The wild-type allele and knockout allele of each mouse was confirmed by genomic DNA PCR (Fig. 1B) and Western blot for protein expression (Fig. 1C) .
Increased Inflammation in Pip4k2c
−/− Mice. Pip4k2c −/− mice bred normally and grew into adulthood, displaying no obvious growth or behavioral abnormalities (Fig. S1 A-E). Unlike Pip4k2b −/− mice, these mice did not have enhanced insulin sensitivity and were not protected from obesity on a high-fat diet (Fig. S1 A-E were incubated with anti-CD3, anti-B220, and anti-Mac2 antibodies, respectively.
Because a SNP (rs1678542) near the human PIP4K2C locus has been linked to autoimmunity, we examined whether Pip4k2c −/− mice exhibit any inflammatory phenotype. We carried out a complete necropsy of Pip4k2c −/− mice at different ages. We found that immune cells formed clusters in the organs of mature Pip4k2c −/− mice (8-14 mo of age). The immune cell infiltration was observed in the liver, kidney, salivary glands, lungs, and intestine of the mice (Fig. 1D and Fig. S1F ). To measure the surface area of infiltrating immune cells in the liver, we paraformaldehyde fixed and paraffin embedded liver tissues and performed H&E staining. The ratio of immune infiltrates per total area was significantly increased in the Pip4k2c −/− mice ( Fig.  1D) , which indicated that the Pip4k2c −/− mice developed chronic inflammation without a specific trigger such as infection or injuries. To identify which type of immune cells infiltrated the organs, we stained the liver tissue sections with anti-CD3, anti-B220, and anti-Mac2 antibodies. The infiltrating immune cells in the Pip4k2c −/− livers consisted of mostly CD3 + T cells and B220 + B cells (Fig. 1E) .
Moreover, the plasma levels of various proinflammatory cytokines increased in the Pip4k2c −/− mice, including the Th1-type cytokines IFNγ, IL-12, and IL-2 ( Fig. 2A) . Additionally, IL-17 and IFNγ secreted by CD4 + T cells isolated from spleen were higher in the Pip4k2c −/− mice ( Fig. 2B ). As T-cell cytokines can affect Ig class switching, we performed Ig isotyping. It is known that IL-17 drives B cells to undergo preferential isotype class switching to IgG3 and IgG2a (15). We found that the level of IgG3 increased in the plasma of Pip4k2c −/− mice, which agreed with the increase in IL-17 levels (Fig. 2C) .
T Cells Are Hyperactivated in Pip4k2c
−/− Mice. Flow cytometry was used to determine the activity of T cells by counting CD44
+ and CD62L + T cells. We found that Pip4k2c −/− mice have more CD44
+ -activated T cells and fewer CD62L
+ naïve T cells compared with the wild-type mice (Fig. 2D ). These data suggested that T cells were more activated in Pip4k2c −/− mice. Also, Pip4k2c
−/− mice showed increased CD4 + and CD8 + populations, indicating an increase of Th cells and cytotoxic T cells (Fig. S1G) .
To investigate proliferation of T cells, we isolated CD4 + T cells from the spleens from Pip4k2c −/− mice and wild-type mice. The cells were seeded in 96-well plates coated with anti-CD3 and anti-CD28. After 48 h of culture, 3 H-thymidine was added for another 16 h before measuring the 3 H-thymidine incorporation (Fig. 2E) . The Pip4k2c −/− T cells showed significantly higher proliferation rates than T cells from wild-type mice. In accordance with increased T-cell activation in Pip4k2c −/− mice, the number of Foxp3 + CD4 + Treg cells decreased in Pip4k2c −/− mice (Fig. 2F) . Therefore, these results indicate that Pip4k2c −/− mice developed inflammation with an activation of T cells.
Increased mTORC1 Signaling in Pip4k2c
−/− Mice. Because the immune system is hyperactivated in Pip4k2c −/− mice, as indicated by an increase in inflammation concomitantly with an increase in T-cell activation, an increase in Th-cell population and a decrease in Treg-cell population, we next investigated if mTORC1 signaling, which is known to regulate diverse immune cell types, (including T cells, macrophages, dendritic cells, neutrophils, and mast cells) was altered in Pip4k2c −/− mice. We found that phosphorylation of p70-S6K on threonine 389 (Thr389, a direct substrate of mTORC1) was increased in kidney, liver, brain, and muscle tissues from Pip4k2c −/− mice compared with wild-type mice (Fig. 3A) . Phosphorylation of Thr389 of p70-S6K was also enhanced in spleen, the major immune system organ (Fig. 3B) . Levels of mature SREBP1 have recently been shown to be a downstream reporter for mTORC1 activity (16) . Consistent with the increased p70-S6K phosphorylation, we also found that levels of mature SREBP1 were significantly higher in various tissues from the Pip4k2c −/− mice (Fig. 3A) . On the other hand, other upstream and downstream components of the mTORC1 pathway, including Akt, AMPK, PDK1, GSK3α/β, and 4E-BP1, did not exhibit significant changes in phosphorylation sites that regulate the activity of this pathway (Fig. S2) . The failure to see significant changes in these other components probably reflects robust feedback control at each of these steps and further supports the concept that Pip4k2c regulates a step quite proximal to mTORC1. These results indicate that mTORC1 signaling is highly activated in Pip4k2c −/− mice, which suggests that increased mTORC1 signaling could explain the hyperactive immune system in Pip4k2c −/− mice.
Rapamycin Reduces mTORC1 Signaling and the Inflammatory Phenotypes in Pip4k2c
−/− Mice. We next examined whether rapamycin, the allosteric mTORC1 inhibitor, could reduce the inflammatory phenotype of Pip4k2c −/− mice. Pip4k2c wild-type and knockout mice were intraperitoneally injected with either vehicle or rapamycin (3 mg·kg
) once a day for 2 wk. Blood was withdrawn 2 wk before the treatment and 24 h after the first treatment. On the final day, blood, liver, and spleen were collected. Using protein lysates from the liver and spleen, we performed SDS/PAGE and Western blot. We found that Thr389 of p70-S6K was still hyperphosphorylated in liver and spleen tissues of Pip4k2c −/− mice treated with vehicle control for 2 wk. However, in the rapamycin-treated Pip4k2c −/− mice, p70-S6K phosphorylation on Thr389 was reduced to the levels seen in tissues from wild-type mice, indicating that rapamycin had suppressed mTORC1 signaling (Fig. 4 A and B) .
The levels of plasma cytokines were measured in the control and rapamycin-treated mice. In agreement with the results in Fig. 2A , before rapamycin treatment the Pip4k2c −/− mice exhibited very high plasma levels of IL-12(p40) and IFNγ compared with levels in plasma of wild-type mice. The plasma level of IL-12(p40) in Pip4k2c −/− mice was reduced to the level observed in wild-type mice at 24 h of rapamycin treatment and remained suppressed after 2 wk of treatment. Rapamycin had no shows the ratio of p70-S6K Thr389 phosphorylation over total p70-S6K. The results are presented as means ± SE of the means. *P < 0.05. (C) Changes in plasma cytokine levels after treatment with rapamycin. Plasma cytokines were detected using multiplex cytokine ELISA. Plasma was collected before the treatment ("before"), 24 h after the first treatment ("1 day"), and a day after the final treatment ("14 day") from the following four groups: wild type with vehicle, wild type with rapamycin (3 mg·kg significant effect on plasma IL-12(p40) in wild-type mice. IFNγ levels decreased somewhat in both wild-type and Pip4k2c −/− mice at 24 h after the first treatment with rapamycin. However, after 2 wk of treatment with rapamycin, IFNγ levels in both wildtype and Pip4k2c −/− mice returned to the basal levels (the level before any treatment). On the other hand, IL-2 and IL-12(p70) levels did not significantly change in the Pip4k2c −/− or wild-type mice in response to rapamycin treatment (Fig. S1H ). More strikingly, we found that the area of immune infiltrates in the livers of rapamycin-treated Pip4k2c −/− mice was dramatically decreased after 2 wk of rapamycin treatment (Fig. 4D) . These data collectively indicate that inhibition of mTORC1 by rapamycin partially reduced the inflammatory phenotypes in Pip4k2c −/− mice.
Discussion
Here we report the generation of Pip4k2c −/− mice and show that Pip4k2c −/− mice have hyperactivated immune systems. Pip4k2c
−/− mice were viable with a normal lifespan and did not show any specific abnormality until they were older than 8 mo. But among the older mice at ages between 8 mo and 14 mo, Pip4k2c −/− mice displayed increased immune infiltrates in various tissues, including liver, intestine, kidney, and lungs. These infiltrating immune cells were mostly T cells and B cells. Moreover, we found that plasma of Pip4k2c −/− mice contained high levels of proinflammatory Th1-type cytokines such as IFNγ, IL-12, and IL-2. Importantly, the increase in Th cells and the decrease in Treg cells in Pip4k2c −/− mice reflect the inflammatory phenotype of these mice. Furthermore, the increase in CD44 + T-cell population (central memory T cells) in these mice also supports the hyperactivation of their immune system. Interestingly, mTORC1 downstream components p70-S6K and SREBP1 were activated in Pip4k2c −/− mouse tissues. Because mTORC1 signaling directs the immune system by regulating diverse immune cell types, a possibility that other immune cells in addition to T cells contribute to the inflammatory phenotype of these mice would be interesting to investigate further.
Moreover, after 2 wk of rapamycin treatment, the inflammatory phenotypes as well as the mTORC1 signaling that were enhanced in the Pip4k2c −/− mice decreased. These results suggested that increased activation of mTORC1 signaling in Pip4k2c −/− mice could be responsible for the chronic inflammation in Pip4k2c −/− mice. These results are in agreement with the correlation between the SNP (rs1678542) in the PIP4K2C locus and familial autoimmunity in humans and suggest that the SNP may suppress expression of PI5P4Kγ protein. Our current model is that loss of PI5P4Kγ results in activation of mTORC1 signaling and that this results in increased inflammation, partially through up-regulation of Th cells.
Whereas high rheumatoid factor levels are often associated with autoimmune diseases, they do not always correlate. We measured the levels of rheumatoid factor from Pip4k2c −/− mice and found that the levels of rheumatoid factor were not elevated in the case of Pip4k2c −/− mice (Fig. S3B ). In addition, the sizes of organs of Pip4k2c −/− mice were not different from wild-type mice. However, we found that Pip4k2c −/− mice older than 12 mo occasionally exhibit pale livers (Fig. S3C) . So we analyzed liver function parameter proteins and metabolites using plasma from Pip4k2c −/− mice (Fig. S3A) . There was an increase in aspartate transaminase (AST) and a decrease in blood urea nitrogen (BUN), without a significant change in alanine transaminase (ALT) and other metabolites. These high AST and low BUN results suggest liver damage in Pip4k2c −/− mice, the mechanism of which would be intriguing to investigate further.
The mechanism by which the immune system is hyperactivated in Pip4k2c −/− mice has not yet been fully elucidated. Our studies suggest that mTORC1, which regulates the immune system in diverse aspects, including modulating T-cell differentiation and activation (12) , is required to maintain the inflammatory phenotype in Pip4k2c −/− mice. The simplest explanation for the observed autoimmunity is that the protein encoded by Pip4k2c (PI5P4Kγ) plays a role in suppressing the function of the related and much more highly active enzymes PI5P4Kα and PI5P4Kβ when mTORC1 signaling is too high and that this provides feedback suppression of mTORC1 signaling to maintain homeostasis in the T-cell population. However, because these studies are based on germline deletion of Pip4k2c in all tissues, it is possible that non-T-cell autonomous events in other tissues contribute to the autoimmunity observed. This question is currently being addressed by generation of mice with T-cell-specific deletion of Pip4k2c.
The biochemical mechanisms by which PI5P4Kγ might provide feedback inhibition of mTORC1 signaling is not clear. The fact that PI5P4Kγ has very low activity compared with PI5P4Kα and PI5P4Kβ but forms heterodimeric complexes with these active enzymes suggests that its major role is to regulate the localization and/or activity of PI5P4Kα and PI5P4Kβ. As discussed in the introduction, it was reported by Mackey et al. (6) that PI5P4Kγ is phosphorylated by mTORC1 on S324 and S328. Interestingly, Mackey et al. (6) found that expression of a S324A/ S328A double-mutant form of PI5P4Kγ in HeLa cells enhanced mTORC1 signaling, whereas expression of a phosphomimetic mutant (S324D/S328D) suppressed mTORC1 signaling. These results are consistent with a model in which PI5P4Kγ can facilitate mTORC1 signaling (perhaps by recruiting the more active enzymes, PI5P4Kα and/or PI5P4Kβ to lysosomes where mTORC1 is activated) and that phosphorylation of PI5P4Kγ at S324 and S328 by mTORC1 provides a negative feedback loop to shut off mTORC1 signaling (perhaps by preventing recruitment of PI5P4Kα and PI5P4Kβ to lysosomes). According to this model, deletion of PI5P4Kγ might impair basal mTORC1 signaling, although PI5P4Kα and/or PI5P4Kβ homodimers or heterodimers could be capable of localizing to lysosomes independent of PI5P4Kγ to maintain mTORC1 signaling in tissues from Pip4k2c −/− mice. In any event, in the absence of PI5P4Kγ the negative feedback control would be eliminated, thereby explaining increased mTORC1 activity in multiple tissues of the Pip4k2c −/− mice. With respect to the abilities of PI5P4Kγ, PI5P4Kα, and PI5P4Kβ to heterodimerize with each other (17) (18) (19) (20) , the genetic interaction among PI5P4Kγ, PI5P4Kα, and PI5P4Kβ is particularly thought provoking. Interestingly, Pip4k2a −/− Pip4k2b −/− double KO mice (5) and Pip4k2b −/− Pip4k2c −/− double KO mice (Fig. S3D) are not viable, whereas Pip4k2a −/− Pip4k2c −/− mice are viable. Thus, mice that only have Pip4k2b are viable, but if this gene is deleted both Pip4k2a and Pip4k2c are critical for viability, indicating that these genes do not have redundant functions and must both be expressed to replicate the function of Pip4k2b. The respective roles for PI5P4Kγ, PI5P4Kα, and PI5P4Kβ are complex. Pip4k2b −/− mice exhibited enhanced insulin sensitivity, smaller body size, and decreased adiposity on a high-fat diet. In contrast, Pip4k2c −/− mice were not different from wild-type mice in these features (Fig. S1 A-E) . In addition to the synthetic lethality for loss of Pip4k2a and Pip4k2b, and for loss of Pip4k2b and Pip4k2c, distinct phenotypes of each of the Pip4k2a −/− , Pip4k2b −/− , and Pip4k2c −/− mice indicate that each isoform has a unique role in vivo.
Of particular interest is the effect of the various knockouts on signaling through the PI3K-Akt-mTORC1 pathway. Deletion of Pip4k2b enhances Akt activation but, surprisingly, does not result in enhanced mTORC1 signaling (4, 5) . Previous studies from many laboratories have shown that impaired mTORC1 activation results in smaller cells and smaller mice (10, 21) . Consistent with the failure of Pip4k2b deletion to link Akt activation to mTORC1 activation, the Pip4k2b −/− mice are smaller than wildtype littermates. Although deletion of Pip4k2a results in no observable phenotypes, deletion of a single allele of Pip4k2a in the context of deletion of both alleles of Pip4k2b results in even smaller mice. These data indicate that Pip4k2a and PIP4k2b suppress PI3K-Akt activation but facilitate mTORC1 activation. This model is consistent with the observation that deletion of the single form of PIP4K2 in flies causes suppression of TORC1 activation and suppression of growth (7) . To determine the epistasis among the multiple mammalian enzymes, phenotypes of the viable double knockout mice will need to be better examined.
Finally, the results that we present here support the association of a SNP in the PIP4K2C locus with autoimmunity, suggesting that PI5P4Kγ expression is probably low in autoimmune patients with the SNP near the PIP4K2C locus. Our observation that treating Pip4k2c −/− mice with rapamycin reduced the inflammatory phenotype by decreasing the activation of mTORC1 indicates that drugs that target mTORC1 signaling are likely to be effective for patients with familial autoimmunity that correlates with the SNP (rs1678542) near the PIP4K2C locus. The primer pair pwtF/pwtR amplifies a fragment (∼0.5 kb) in wild type and the primer pair pkoF/pkoR amplifies a fragment (∼0.5 kb) in knockout.
Preparation of Mouse Tissues for Immunohistochemistry. Tissues were removed from the killed mice and washed with PBS. The samples were fixed in 10% (vol/vol) buffered formalin for 24 h and paraffin embedded. H&E staining was performed at the Rodent Histopathology Core at the DanaFarber/Harvard Cancer Center. Staining the immune infiltrates in liver tissue was performed at the Laboratory of Comparative Pathology at Memorial Sloan Kettering Cancer Center. The samples were microsectioned, deparaffinized, rehydrated, and heated with a pressure cooker to 125°C for 30 s in citrate buffer for antigen retrieval and then incubated with peroxidase and protein blocking reagents, respectively, for 5 min. Sections were then incubated with anti-CD3, anti-B220, and anti-Mac2 antibodies, respectively.
Blood Collection from Mouse and Plasma Preparation. Mouse tails were cut 1 mm from the tip with scissors and blood was collected into prechilled 1.5 mL EDTA-coated Eppendorf tubes (Microvette CB300, Sarstedt). The samples were centrifuged for 15 min at 825 × g at 4°C. The supernatants were transferred to new Eppendorf tubes and passed through 0.22-μm filters (centrifuging for 1 min at 5,000 rpm at 4°C).
Measurement of Plasma Cytokines. Mouse plasma was prepared as described above. Plasma cytokine levels were measured using multiplex cytokine assay at Eve Technologies. To measure cytokines in our laboratory, the BD Bioscience ELISA kit for IL-12, IFNγ, and IL-2 (M1270, MIF00, and M2000, respectively) was used according to the manufacturer's protocol.
T-Cell Proliferation. Cells were grown in DMEM supplemented with 10% FCS, β-mercaptoethanol, l-glutamine, gentamicin sulfate, and penicillin/streptomycin. For the thymidine proliferation assay, 5 × Mean thymidine incorporation in triplicate wells was measured using a β-counter (LS 5000; Beckman Coulter).
Rapamycin Treatment of the Mice. For rapamycin treatment, stock solutions (50 mg/mL) were diluted into vehicle [5% (vol/vol) Tween-80, 5% (vol/vol) PEG 400 (polyethylene glycol, molecular weight 400)] in 1× PBS for 2 wk (3 mg·kg −1 ·d −1 ) treatments through i.p. injections. Mice were killed after 2 wk of treatment.
